深部静脈血栓症（DVT）治療薬の世界市場（～2026年）

• 英文タイトル：Global Deep Vein Thrombosis (DVT) Drug Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11584
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は深部静脈血栓症（DVT）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別深部静脈血栓症（DVT）治療薬の競争状況、市場シェア
・世界の深部静脈血栓症（DVT）治療薬市場：種類別市場規模 2015年-2020年（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）
・世界の深部静脈血栓症（DVT）治療薬市場：種類別市場規模予測 2021年-2026年（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）
・世界の深部静脈血栓症（DVT）治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、ドラッグストア）
・世界の深部静脈血栓症（DVT）治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、ドラッグストア）
・北米の深部静脈血栓症（DVT）治療薬市場分析：米国、カナダ
・ヨーロッパの深部静脈血栓症（DVT）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの深部静脈血栓症（DVT）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の深部静脈血栓症（DVT）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの深部静脈血栓症（DVT）治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Bayer、Bristol-Myers Squibb、Pfizer、Sanofi、GSK、Daiichi Sankyo
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market
The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Deep Vein Thrombosis (DVT) Drug Scope and Market Size
Deep Vein Thrombosis (DVT) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Deep Vein Thrombosis (DVT) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer
Bristol-Myers Squibb
Pfizer
Sanofi
GSK
Daiichi Sankyo
…

Market segment by Type, the product can be split into
Blood Thinners
Tissue Plasminogen Activators
Other Drug
Market segment by Application, split into
Hospitals
Clinics
Drug Stores

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Deep Vein Thrombosis (DVT) Drug Revenue
1.4 Market by Type
1.4.1 Global Deep Vein Thrombosis (DVT) Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Thinners
1.4.3 Tissue Plasminogen Activators
1.4.4 Other Drug
1.5 Market by Application
1.5.1 Global Deep Vein Thrombosis (DVT) Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Deep Vein Thrombosis (DVT) Drug Market Perspective (2015-2026)
2.2 Global Deep Vein Thrombosis (DVT) Drug Growth Trends by Regions
2.2.1 Deep Vein Thrombosis (DVT) Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Deep Vein Thrombosis (DVT) Drug Historic Market Share by Regions (2015-2020)
2.2.3 Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Deep Vein Thrombosis (DVT) Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Deep Vein Thrombosis (DVT) Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Deep Vein Thrombosis (DVT) Drug Players by Market Size
3.1.1 Global Top Deep Vein Thrombosis (DVT) Drug Players by Revenue (2015-2020)
3.1.2 Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Deep Vein Thrombosis (DVT) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Deep Vein Thrombosis (DVT) Drug Market Concentration Ratio
3.2.1 Global Deep Vein Thrombosis (DVT) Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Deep Vein Thrombosis (DVT) Drug Revenue in 2019
3.3 Deep Vein Thrombosis (DVT) Drug Key Players Head office and Area Served
3.4 Key Players Deep Vein Thrombosis (DVT) Drug Product Solution and Service
3.5 Date of Enter into Deep Vein Thrombosis (DVT) Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Deep Vein Thrombosis (DVT) Drug Historic Market Size by Type (2015-2020)
4.2 Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)
5.2 Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
6.2 Deep Vein Thrombosis (DVT) Drug Key Players in North America (2019-2020)
6.3 North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
6.4 North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

7 Europe
7.1 Europe Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
7.2 Deep Vein Thrombosis (DVT) Drug Key Players in Europe (2019-2020)
7.3 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
7.4 Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

8 China
8.1 China Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
8.2 Deep Vein Thrombosis (DVT) Drug Key Players in China (2019-2020)
8.3 China Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
8.4 China Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

9 Japan
9.1 Japan Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
9.2 Deep Vein Thrombosis (DVT) Drug Key Players in Japan (2019-2020)
9.3 Japan Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
9.4 Japan Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
10.2 Deep Vein Thrombosis (DVT) Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

11 India
11.1 India Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
11.2 Deep Vein Thrombosis (DVT) Drug Key Players in India (2019-2020)
11.3 India Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
11.4 India Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Deep Vein Thrombosis (DVT) Drug Market Size (2015-2020)
12.2 Deep Vein Thrombosis (DVT) Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020)
12.4 Central & South America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Deep Vein Thrombosis (DVT) Drug Introduction
13.1.4 Bayer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Deep Vein Thrombosis (DVT) Drug Introduction
13.2.4 Bristol-Myers Squibb Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Deep Vein Thrombosis (DVT) Drug Introduction
13.3.4 Pfizer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Deep Vein Thrombosis (DVT) Drug Introduction
13.4.4 Sanofi Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 GSK
13.5.1 GSK Company Details
13.5.2 GSK Business Overview
13.5.3 GSK Deep Vein Thrombosis (DVT) Drug Introduction
13.5.4 GSK Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020)
13.5.5 GSK Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview
13.6.3 Daiichi Sankyo Deep Vein Thrombosis (DVT) Drug Introduction
13.6.4 Daiichi Sankyo Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Deep Vein Thrombosis (DVT) Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Deep Vein Thrombosis (DVT) Drug Revenue
Table 3. Ranking of Global Top Deep Vein Thrombosis (DVT) Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Deep Vein Thrombosis (DVT) Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Thinners
Table 6. Key Players of Tissue Plasminogen Activators
Table 7. Key Players of Other Drug
Table 8. Global Deep Vein Thrombosis (DVT) Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Deep Vein Thrombosis (DVT) Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Deep Vein Thrombosis (DVT) Drug Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2015-2020)
Table 12. Global Deep Vein Thrombosis (DVT) Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Deep Vein Thrombosis (DVT) Drug Market Growth Strategy
Table 18. Main Points Interviewed from Key Deep Vein Thrombosis (DVT) Drug Players
Table 19. Global Deep Vein Thrombosis (DVT) Drug Revenue by Players (2015-2020) (Million US$)
Table 20. Global Deep Vein Thrombosis (DVT) Drug Market Share by Players (2015-2020)
Table 21. Global Top Deep Vein Thrombosis (DVT) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Vein Thrombosis (DVT) Drug as of 2019)
Table 22. Global Deep Vein Thrombosis (DVT) Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Deep Vein Thrombosis (DVT) Drug Product Solution and Service
Table 25. Date of Enter into Deep Vein Thrombosis (DVT) Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 28. Global Deep Vein Thrombosis (DVT) Drug Market Size Share by Type (2015-2020)
Table 29. Global Deep Vein Thrombosis (DVT) Drug Revenue Market Share by Type (2021-2026)
Table 30. Global Deep Vein Thrombosis (DVT) Drug Market Size Share by Application (2015-2020)
Table 31. Global Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 32. Global Deep Vein Thrombosis (DVT) Drug Market Size Share by Application (2021-2026)
Table 33. North America Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 35. North America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 36. North America Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 37. North America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 38. North America Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 39. Europe Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 41. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 43. Europe Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 45. China Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 46. China Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 47. China Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 48. China Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 49. China Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 50. China Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 51. Japan Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 53. Japan Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 55. Japan Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 59. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 61. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 63. India Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 64. India Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 65. India Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 66. India Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 67. India Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 68. India Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Deep Vein Thrombosis (DVT) Drug Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Deep Vein Thrombosis (DVT) Drug Market Share (2019-2020)
Table 71. Central & South America Deep Vein Thrombosis (DVT) Drug Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Deep Vein Thrombosis (DVT) Drug Market Share by Type (2015-2020)
Table 73. Central & South America Deep Vein Thrombosis (DVT) Drug Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Deep Vein Thrombosis (DVT) Drug Market Share by Application (2015-2020)
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Product
Table 78. Bayer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 79. Bayer Recent Development
Table 80. Bristol-Myers Squibb Company Details
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Product
Table 93. Sanofi Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 94. Sanofi Recent Development
Table 95. GSK Company Details
Table 96. GSK Business Overview
Table 97. GSK Product
Table 98. GSK Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 99. GSK Recent Development
Table 100. Daiichi Sankyo Company Details
Table 101. Daiichi Sankyo Business Overview
Table 102. Daiichi Sankyo Product
Table 103. Daiichi Sankyo Revenue in Deep Vein Thrombosis (DVT) Drug Business (2015-2020) (Million US$)
Table 104. Daiichi Sankyo Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deep Vein Thrombosis (DVT) Drug Market Share by Type: 2020 VS 2026
Figure 2. Blood Thinners Features
Figure 3. Tissue Plasminogen Activators Features
Figure 4. Other Drug Features
Figure 5. Global Deep Vein Thrombosis (DVT) Drug Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Deep Vein Thrombosis (DVT) Drug Report Years Considered
Figure 10. Global Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions: 2020 VS 2026
Figure 12. Global Deep Vein Thrombosis (DVT) Drug Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Deep Vein Thrombosis (DVT) Drug Market Share by Players in 2019
Figure 15. Global Top Deep Vein Thrombosis (DVT) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Vein Thrombosis (DVT) Drug as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Deep Vein Thrombosis (DVT) Drug Revenue in 2019
Figure 17. North America Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Deep Vein Thrombosis (DVT) Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

動脈血栓症薬の世界市場（～2026年）

Global Arterial Thrombosis Drug Market Insights and Forecast to 2026
MRC2-11QY02682 2020年11月20日 113Pages
当調査資料は動脈血栓症薬のグローバル市場について調査・分析したレポートです。種類別（AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年）

Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY05000 2020年11月20日 90Pages
当調査資料は静脈血栓塞栓症（VTE）治療薬のグローバル市場について調査・分析したレポートです。種類別（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）市場規模、用途別（病院、ASC、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

性感染症（STD）治療薬の世界市場（～2026年）

Global Sexually Transmitted Disease (STD ) Drug Market Insights and Forecast to 2026
MRC2-11QY09405 2020年11月25日 115Pages
当調査資料は性感染症（STD）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗ウイルス剤、ワクチン）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

薬物アレルギー治療/治療薬の世界市場（～2026年）

Global Drug Allergy Treatments and Drugs Market Insights and Forecast to 2026
MRC2-11QY05438 2020年11月20日 113Pages
当調査資料は薬物アレルギー治療/治療薬のグローバル市場について調査・分析したレポートです。種類別（ペニシリン・関連薬、サルファ剤、インスリン、ヨウ素、化学療法薬、その他）市場規模、用途別（病院、診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業）市場規模、地域別（北米、米国、カナダ、ヨーロ...

オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年）

Global Opioid Induced Constipation (OIC) Drug Market Insights and Forecast to 2026
MRC2-11QY08386 2020年11月20日 150Pages
当調査資料はオピオイド誘発性便秘（OIC）治療薬のグローバル市場について調査・分析したレポートです。種類別（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

消化管間質腫瘍（GIST）治療薬の世界市場（～2026年）

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insights and Forecast to 2026
MRC2-11QY06723 2020年11月20日 148Pages
当調査資料は消化管間質腫瘍（GIST）治療薬のグローバル市場について調査・分析したレポートです。種類別（アンカセルチブ、塩酸アナグレリドCR、APG-1351、ビニメチニブ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

静脈瘤治療の世界市場（～2026年）

Global Varicose Vein Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04979 2020年11月20日 96Pages
当調査資料は静脈瘤治療のグローバル市場について調査・分析したレポートです。種類別（アブレーション装置、高周波アブレーション装置、レーザーアブレーション装置、静脈閉鎖製品）市場規模、用途別（静脈内アブレーション、注射硬化療法、外科的結紮/剥離）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

網膜静脈閉塞症治療薬の世界市場（～2026年）

Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04502 2020年11月20日 92Pages
当調査資料は網膜静脈閉塞症治療薬のグローバル市場について調査・分析したレポートです。種類別（網膜静脈分枝閉塞症、網膜中心静脈閉塞症）市場規模、用途別（病院、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

医薬品開発・発見用人工知能（AI）の世界市場（～2026年）

Global Artificial Intelligence For Drug Development and Discovery Market Size, Status and Forecast 2020-2026
MRC2-11QY10900 2020年11月25日 96Pages
当調査資料は医薬品開発・発見用人工知能（AI）のグローバル市場について調査・分析したレポートです。種類別（ターゲット識別、分子スクリーニング、デノボドラッグデザイン・ドラッグ最適化、前臨床・臨床試験）市場規模、用途別（製薬・バイオ技術企業、委託研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッ...

脳深部刺激療法（DBS）の世界市場（～2026年）

Global Deep Brain Stimulation Market Size, Status and Forecast 2020-2026
MRC2-11QY11581 2020年11月25日 96Pages
当調査資料は脳深部刺激療法（DBS）のグローバル市場について調査・分析したレポートです。種類別（リード、エクステンション）市場規模、用途別（PD、癲癇、ジストニア、OCD）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

動脈血栓症薬の世界市場（～2026年） Market Analysis and Insights: Global Arterial Thrombosis Drug Market The global Arterial Thrombosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Arterial Thrombosis Drug Scope and Market Size Arterial Thrombosi…
医薬品開発・発見用人工知能（AI）の世界市場（～2026年） Market Analysis and Insights: Global Artificial Intelligence For Drug Development and Discovery Market The global Artificial Intelligence For Drug Development and Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With …
網膜静脈閉塞症治療薬の世界市場（～2026年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…
静脈瘤治療の世界市場（～2026年） Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the skin. These are often seen near the legs. Market Analysis and Insights: Global Varicose Vein Treatment Market The global Varicose Vein Treatment market size is projected to reach US$ 401.9 million by …
創薬アウトソーシングの世界市場（～2026年） Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking …